Sarah O’Connell

机构：National Institutes of Health, Cork University Hospital, National Institute of Allergy and Infectious Diseases, Children's Advocacy Center · ORCID：0000-0002-1645-0722

发表论文 108 篇 · 总被引 7906 次 · h-index 35

代表论文

• An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults (2023 · Science Translational Medicine · 被引 101)
• Developing energy flexibility in clusters of buildings: A critical analysis of barriers from planning to operation (2023 · Energy and Buildings · 被引 71)
• Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial (2023 · The Lancet · 被引 66)
• Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection (2023 · Neurology Neuroimmunology & Neuroinflammation · 被引 55)
• Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial (2023 · Science Translational Medicine · 被引 49)
• Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial (2023 · The Lancet Infectious Diseases · 被引 25)